Related Experiment Video
Updated: Mar 2, 2026
Evaluating Cell Death Using Cell-Free Supernatant of Probiotics in Three-Dimensional Spheroid Cultures of Colorectal Cancer Cells
Published on: June 13, 2020
Practice Patterns of Hereditary Ovarian Cancer Management in Korea
Min Chul Choi1, Myong Cheol Lim, Maria Lee
1*Comprehensive Gynecologic Cancer Center, Department of Obstetrics and Gynecology, CHA Bundang Medical Center, CHA University, Seongnam; †Gynecologic Cancer Branch, Center for Uterine Cancer, Center for Clinical Trials, and ‡Department of Cancer Control and Policy, Graduate School of Cancer Science and Policy, National Cancer Center, Goyang; §Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul; ∥Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Samsung Changwon Hospital, School of Medicine, Sungkyunkwan University, Changwon; ¶Department of Obstetrics and Gynecology, Seoul National University Bundang Hospital, Seongnam; #Department of Obstetrics and Gynecology, Pusan National University Yangsan Hospital, Pusan National University School of Medicine, Yangsan-si; **Department of Obstetrics and Gynecology, Samsung Medical Center, School of Medicine, Sungkyunkwan University, Seoul; and ††Department of Obstetrics and Gynecology, Ajou University School of Medicine, Suwon, Korea.
Objective:
This study aims to evaluate practice patterns for managing hereditary ovarian cancer among Korean gynecologic oncologic physicians.
Methods:
Members of the Korean Society of Gynecologic Oncology participated in the inaugural Hereditary Gynecologic Cancer Symposium or were invited to this survey by e-mail from January to February 2016. The survey was conducted using a self-administered questionnaire.
Results:
Most physicians (66.7%, 36/54) responded to draw a pedigree of patients with a family history. The rate of genetic test recommendations for patients at risk for ovarian cancer was high (96.3%, 52/54). Physicians tended to select appropriate candidates for the genetic test. Of the respondents, genetic counseling was commonly performed before the genetic test (76.6%, 36/47) and provided by the specialist consultant(s) (78.7%, 37/47) or the physician alone (12.8%, 6/47). Participants showed mature response to risk management for the BRCA carriers: at least annual gynecologic surveillance (89.4%, 42/47), recommendation for chemoprevention (76.6%, 36/47), and advice for risk-reducing salpingo-oophorectomy (85.1%, 40/47). Risk-reducing salpingectomy with delayed oophorectomy as an alternative to risk-reducing salpingo-oophorectomy was considered to recommend in most of respondents (91.5%, 43/47).
Conclusions:
Gynecologic oncologic physicians in Korea had high awareness to genetic risk assessment, candidate selection to genetic test, and risk-reducing strategies for the management of hereditary ovarian cancer.
